- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Cedara introduces 3D plug-ins
Canadian software developer Cedara has released a suite of 3D software plug-in components for examining CT and MR images. The products, collectively called Cedara Vivace, allow equipment manufacturers wanting to offer advanced 3D visualization to easily
Canadian software developer Cedara has released a suite of 3D software plug-in components for examining CT and MR images. The products, collectively called Cedara Vivace, allow equipment manufacturers wanting to offer advanced 3D visualization to easily plug the new software into imaging workstations already installed in the field or into new medical imaging devices. In market previews, companies reported being able to plug Vivace into their products in less than a week. Cedara Vivace adapts to the look and feel of its host application. Once plugged in, the 3D software becomes an integral part of the workstation. The suite offers four distinct rendering modes: maximum intensity projection, minimum intensity projection, shaded volume, and unshaded volume, as well as multiplanar reformatting.
New Study Assesses Long-Term Outcomes of PSMA PET Use in PCa Recurrence Cases
October 24th 2024For patients with biochemical recurrence of prostate cancer, PSMA PET imaging may facilitate a 12.8 percent lower incidence of prostate cancer mortality in contrast to the combination of CT and bone scan, according to long-term outcome estimates from a new decision-analytic modeling study.
Can Diffusion MRI Predict Patient Response to Neoadjuvant Chemotherapy for Breast Cancer?
October 23rd 2024A model emphasizing time-dependent diffusion MRI was 15 percent more effective than apparent diffusion coefficient (ADC) measurements at predicting pathologic complete response to neoadjuvant chemotherapy for women with breast cancer, according to new research.
